We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $29.90, moving -3.05% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.2%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.04%.
The stock of company has risen by 1.68% in the past month, leading the Finance sector's loss of 4.84% and the S&P 500's loss of 0.35%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.11, reflecting a 79.25% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $4.72 billion, up 58.14% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.83 per share and revenue of $18.81 billion. These totals would mark changes of +208.28% and +60.77%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 18.79% increase. Oscar Health, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy).
Investors should also note Oscar Health, Inc.'s current valuation metrics, including its Forward P/E ratio of 16.82. This valuation marks a premium compared to its industry average Forward P/E of 9.52.
We can also see that OSCR currently has a PEG ratio of 0.34. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 0.9 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. With its current Zacks Industry Rank of 91, this industry ranks in the top 37% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $29.90, moving -3.05% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.2%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.04%.
The stock of company has risen by 1.68% in the past month, leading the Finance sector's loss of 4.84% and the S&P 500's loss of 0.35%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.11, reflecting a 79.25% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $4.72 billion, up 58.14% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.83 per share and revenue of $18.81 billion. These totals would mark changes of +208.28% and +60.77%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 18.79% increase. Oscar Health, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy).
Investors should also note Oscar Health, Inc.'s current valuation metrics, including its Forward P/E ratio of 16.82. This valuation marks a premium compared to its industry average Forward P/E of 9.52.
We can also see that OSCR currently has a PEG ratio of 0.34. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 0.9 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. With its current Zacks Industry Rank of 91, this industry ranks in the top 37% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.